{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:38:20Z","timestamp":1793860700574,"version":"4.6.1"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"DOI":"10.1186\/s12958-025-01409-9","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T06:17:08Z","timestamp":1751523428000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The effectiveness of nutritional supplements in improving polycystic ovary syndrome in women: a systematic review and network meta-analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Guanhua","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianchang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"issue":"2","key":"1409_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.mcna.2022.10.004","volume":"107","author":"S Shrivastava","year":"2023","unstructured":"Shrivastava S, Conigliaro RL. Polycystic Ovarian Syndrome. Med Clin North Am. 2023;107(2):227\u201334.","journal-title":"Med Clin North Am"},{"key":"1409_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","volume":"106","author":"D Liz Neva","year":"2016","unstructured":"Liz Neva D, Saturnia L, Walker W, Barkat S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Sterile. 2016;106:6\u201315.","journal-title":"Fertil Sterile"},{"key":"1409_CR3","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","volume":"370","author":"RJ Norman","year":"2007","unstructured":"Norman RJ, Dewily D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet. 2007;370:685\u201397.","journal-title":"Lancet"},{"issue":"9","key":"1409_CR4","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","volume":"10","author":"AE Joham","year":"2022","unstructured":"Joham AE, Norman RJ, Stener-Victorin E, Legro RS, Franks S, Moran LJ, et al. Polycystic ovary syndrome. Lancet Diabetes Endocrinol. 2022;10(9):668\u201380.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"1409_CR5","doi-asserted-by":"publisher","first-page":"943","DOI":"10.18502\/ijrm.v22i12.18061","volume":"22","author":"SS Bahreiny","year":"2024","unstructured":"Bahreiny SS, Ahangarpour A, Harooni E, Amraei M, Aghaei M, Mohammadpour FR. Closer look at circulating nitric oxide levels and their association with polycystic ovary syndrome: A meta-analytical exploration. IJRM. 2024;22(12):943\u201362.","journal-title":"IJRM"},{"issue":"7","key":"1409_CR6","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1210\/jc.2018-02548","volume":"104","author":"E Carmina","year":"2019","unstructured":"Carmina E, Azziz R, Bergfeld W, Escobar-Morreale HF, Futterweit W, Huddleston H, et al. Female Pattern Hair Loss and Androgen Excess: A Report from the Multidisciplinary Androgen Excess and PCOS Committee. J Clin Endocrinol Metab. 2019;104(7):2875\u201391.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1409_CR7","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1080\/15548627.2021.1938914","volume":"17","author":"S Kumariya","year":"2021","unstructured":"Kumariya S, Ubba V, Jha RK, Gayen JR. Autophagy in ovary and polycystic ovary syndrome: role, dispute and future perspective. Autophagy. 2021;17(10):2706\u201333.","journal-title":"Autophagy"},{"issue":"2","key":"1409_CR8","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s40200-024-01461-z","volume":"23","author":"SS Bahreiny","year":"2024","unstructured":"Bahreiny SS, Ahangarpour A, Aghaei M, Mohammadpour Fard R, Jalali Far MA, Sakhavarz T. A closer look at Galectin-3: its association with gestational diabetes mellitus revealed by systematic review and meta-analysis. J Diabetes Metab Disord. 2024;23(2):1621\u201333.","journal-title":"J Diabetes Metab Disord"},{"issue":"4","key":"1409_CR9","doi-asserted-by":"publisher","first-page":"288","DOI":"10.23736\/S0026-4946.20.05861-2","volume":"72","author":"ME Street","year":"2020","unstructured":"Street ME, Cirillo F, Catellani C, Dauriz M, Lazzeroni P, Sartori C, et al. current treatment for polycystic ovary syndrome: focus on adolescence. Minerva Pediatr. 2020;72(4):288\u2013311.","journal-title":"Minerva Pediatr"},{"issue":"6","key":"1409_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1159\/000519302","volume":"77","author":"X Che","year":"2021","unstructured":"Che X, Chen Z, Liu M, Mo Z. Dietary Interventions: A Promising Treatment for Polycystic Ovary Syndrome. Ann Nutr Metab. 2021;77(6):313\u201323.","journal-title":"Ann Nutr Metab"},{"issue":"4","key":"1409_CR11","first-page":"220","volume":"19","author":"E Gunalan","year":"2018","unstructured":"Gunalan E, Yaba A, Yilmaz B. The effect of nutrient supplementation in the management of polycystic ovary syndrome-associated metabolic dysfunctions: a critical review. J Turk Ger Gynecol Assoc. 2018;19(4):220\u201332.","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"1409_CR12","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.clnesp.2024.07.015","volume":"63","author":"R Mohammadpour Fard","year":"2024","unstructured":"Mohammadpour Fard R, Rashno M, Bahreiny SS. Effects of melatonin supplementation on markers of inflammation and oxidative stress in patients with diabetes: A systematic review and meta-analysis of randomized controlled trials. Clin Nutr ESPEN. 2024;63:530\u20139.","journal-title":"Clin Nutr ESPEN"},{"issue":"4","key":"1409_CR13","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/advances\/nmab141","volume":"13","author":"S Alesi","year":"2022","unstructured":"Alesi S, Ee C, Moran LJ, Rao V, Mousa A. Nutritional Supplements and Complementary Therapies in Polycystic Ovary Syndrome. Adv Nutr. 2022;13(4):1243\u201366.","journal-title":"Adv Nutr"},{"issue":"9","key":"1409_CR14","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.3390\/nu13092938","volume":"13","author":"P Dubey","year":"2021","unstructured":"Dubey P, Reddy S, Boyd S, Bracamontes C, Sanchez S, Chattopadhyay M, et al. Effect of Nutritional Supplementation on Oxidative Stress and Hormonal and Lipid Profiles in PCOS-Affected Females. Nutrients. 2021;13(9):2938.","journal-title":"Nutrients"},{"key":"1409_CR15","doi-asserted-by":"crossref","unstructured":"Bahreiny Seyed Sobhan, Aghaei Mojtaba, Amraei Mahdi, Dabbagh Mohammad Reza. Exploring the relationship between Hashimoto\u2019s thyroiditis and male fertility: A meta-analytic and meta-regression perspective on hormonal and seminal factors. Asian Pac J Reprod. 2024;13(4):147\u2013159.","DOI":"10.4103\/apjr.apjr_72_24"},{"issue":"4","key":"1409_CR16","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1080\/10408398.2021.1951155","volume":"63","author":"Y Li","year":"2023","unstructured":"Li Y, Tan Y, Xia G, Shuai J. Effects of probiotics, prebiotics, and synbiotics on polycystic ovary syndrome: a systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2023;63(4):522\u201338.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"1409_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12602-019-09559-0","volume":"14","author":"R Tabrizi","year":"2022","unstructured":"Tabrizi R, Ostad Mohammadi V, Akbari M, Lank Arani KB, Vakili S, Peymani P, et al. The Effects of Probiotic Supplementation on Clinical Symptom, Weight Loss, Glycemic Control, Lipid and Hormonal Profiles, Biomarkers of Inflammation, and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis of Randomized Controlled Trials. Probiotics Antimicrob Proteins. 2022;14(1):1\u201314.","journal-title":"Probiotics Antimicrob Proteins"},{"key":"1409_CR18","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.16410","volume":"11","author":"X Hu","year":"2023","unstructured":"Hu X, Wang W, Su X, Peng H, Tan Z, Li Y, et al. Comparison of nutritional supplements in improving glycolipid metabolism and endocrine function in polycystic ovary syndrome: a systematic review and network meta-analysis. Peer J. 2023;11: e16410.","journal-title":"Peer J"},{"issue":"11","key":"1409_CR19","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777\u201384.","journal-title":"Ann Intern Med"},{"key":"1409_CR20","unstructured":"Zawadri JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. Boston (MA): Black-well Scientific;1992."},{"issue":"1","key":"1409_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19\u201325.","journal-title":"Fertil Steril"},{"issue":"2","key":"1409_CR22","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456\u201388.","journal-title":"Fertil Steril"},{"issue":"3","key":"1409_CR23","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000051263","volume":"12","author":"M Oremus","year":"2001","unstructured":"Oremus M, Wolfson C, Perrault A, Demers L, Momoli F, Moride Y. Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer\u2019s disease drug trials. Dement Geriatr Cogn Disord. 2001;12(3):232\u20136.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1409_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343: d5928.","journal-title":"BMJ"},{"key":"1409_CR25","unstructured":"Higgins JPT, Li T, Deeks JJ. Chapter 6: Choosing effect measures and computing estimates of effect. Cochrane handbook for systematic reviews of interventions version 6.3. https:\/\/training.cochrane.org\/handbook\/current\/chapter-06#section-6-5-1-2 (12 November 2021)."},{"key":"1409_CR26","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/0895-4356(92)90054-Q","volume":"45","author":"D Follmann","year":"1992","unstructured":"Follmann D, Elliott P, Suh I, Cutler J. Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol. 1992;45:769\u201373.","journal-title":"J Clin Epidemiol"},{"issue":"28","key":"1409_CR27","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1093\/eurheartj\/ehad211","volume":"44","author":"CA Koch","year":"2023","unstructured":"Koch CA, Kjeldsen EW, Frikke-Schmidt R. Vegetarian or vegan diets and blood lipids: a meta-analysis of randomized trials. Eur Heart J. 2023;44(28):2609\u201322.","journal-title":"Eur Heart J"},{"key":"1409_CR28","doi-asserted-by":"crossref","unstructured":"Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, et al. Updated guidance for trusted systematic reviews: A new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst. Rev. 2019; 10, Ed000142.","DOI":"10.1002\/14651858.ED000142"},{"key":"1409_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106647","volume":"188","author":"J Xia","year":"2023","unstructured":"Xia J, Yu J, Xu H, Zhou Y, Li H, Yin S, et al. Comparative effects of vitamin and mineral supplements in the management of type 2 diabetes in primary care: A systematic review and network meta-analysis of randomized controlled trials. Pharmacol Res. 2023;188: 106647.","journal-title":"Pharmacol Res"},{"issue":"10","key":"1409_CR30","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1007\/s43032-024-01676-8","volume":"31","author":"SS Bahreiny","year":"2024","unstructured":"Bahreiny SS, Ahangarpour A, Rajaei E, Sharifani MS, Aghaei M. Meta-Analytical and Meta-Regression Evaluation of Subclinical Hyperthyroidism\u2019s Effect on Male Reproductive Health: Hormonal and Seminal Perspectives. Reprod Sci. 2024;31(10):2957\u201371.","journal-title":"Reprod Sci"},{"issue":"7","key":"1409_CR31","first-page":"541","volume":"21","author":"H Bahramian","year":"2023","unstructured":"Bahramian H, Sherafatmanesh S, Asadi N, Bakhshi A, Hassan Eftekhari M, Ekramzadeh CM. Effects of single-dose and co-supplementation of vitamin D and omega-3 on metabolic profile in women with polycystic ovary syndrome: An RCT. Int J Reprod Biomed. 2023;21(7):541\u201350.","journal-title":"Int J Reprod Biomed"},{"issue":"7","key":"1409_CR32","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1055\/s-0043-107242","volume":"49","author":"M Maktabi","year":"2017","unstructured":"Maktabi M, Chamani M, Asemi Z. The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind. Placebo-Controlled Trial Horm Metab Res. 2017;49(7):493\u20138.","journal-title":"Placebo-Controlled Trial Horm Metab Res"},{"issue":"12","key":"1409_CR33","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.3390\/nu9121280","volume":"9","author":"M Jamilian","year":"2017","unstructured":"Jamilian M, Foroozanfard F, Rahmani E, Talebi M, Bahmani F, Asemi Z. Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome. Nutrients. 2017;9(12):1280.","journal-title":"Nutrients"},{"issue":"6","key":"1409_CR34","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/cen.12840","volume":"83","author":"F Foroozanfard","year":"2015","unstructured":"Foroozanfard F, Jamilian M, Bahmani F, Talaee R, Talaee N, Hashemi T, et al. Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. Clin Endocrinol (Oxf). 2015;83(6):888\u201394.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"1409_CR35","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1530\/EC-15-0001","volume":"4","author":"G Garg","year":"2015","unstructured":"Garg G, Kachhawa G, Ramot R, Khadgawat R, Tandon N, Sreenivas V, et al. Effect of vitamin D supplementation on insulin kinetics and cardiovascular risk factors in polycystic ovarian syndrome: a pilot study. Endocr Connect. 2015;4(2):108\u201316.","journal-title":"Endocr Connect"},{"issue":"1","key":"1409_CR36","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12958-018-0413-3","volume":"16","author":"M Dastorani","year":"2018","unstructured":"Dastorani M, Aghadavod E, Mirhosseini N, Foroozanfard F, Zadeh Modarres S, Amiri Siavashani M, et al. The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization. Reprod Biol Endocrinol. 2018;16(1):94.","journal-title":"Reprod Biol Endocrinol"},{"issue":"6","key":"1409_CR37","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1080\/09513590.2017.1418311","volume":"34","author":"M Seyyed Abootorabi","year":"2018","unstructured":"Seyyed Abootorabi M, Ayremlou P, Behroozi-Lak T, Nourisaeidlou S. The effect of vitamin D supplementation on insulin resistance, visceral fat and adiponectin in vitamin D deficient women with polycystic ovary syndrome: a randomized placebo-controlled trial. Gynecol Endocrinol. 2018;34(6):489\u201394.","journal-title":"Gynecol Endocrinol"},{"issue":"8","key":"1409_CR38","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1055\/s-0043-112346","volume":"49","author":"F Foroozanfard","year":"2017","unstructured":"Foroozanfard F, Talebi M, Samimi M, Mehrabi S, Badehnoosh B, Jamilian M, et al. Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind. Placebo-Controlled Trial Horm Metab Res. 2017;49(8):612\u20137.","journal-title":"Placebo-Controlled Trial Horm Metab Res"},{"issue":"5","key":"1409_CR39","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s40618-017-0785-9","volume":"41","author":"S Jafari-Sfidvajani","year":"2018","unstructured":"Jafari-Sfidvajani S, Ahangari R, Hozoori M, Mozaffari-Khosravi H, Fallahzadeh H, Nadjarzadeh A. The effect of vitamin D supplementation in combination with low-calorie diet on anthropometric indices and androgen hormones in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial. J Endocrinol Invest. 2018;41(5):597\u2013607.","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"1409_CR40","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.nutres.2012.02.001","volume":"32","author":"HR Ardabili","year":"2012","unstructured":"Ardabili HR, Gargari BP, Farzadi L. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency. Nutr Res. 2012;32(3):195\u2013201.","journal-title":"Nutr Res"},{"issue":"4","key":"1409_CR41","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.clnu.2014.09.015","volume":"34","author":"Z Asemi","year":"2015","unstructured":"Asemi Z, Foroozanfard F, Hashemi T, Bahmani F, Jamilian M, Esmaillzadeh A. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome. Clin Nutr. 2015;34(4):586\u201392.","journal-title":"Clin Nutr"},{"issue":"3","key":"1409_CR42","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.clnu.2020.09.024","volume":"40","author":"N Al-Bayyari","year":"2021","unstructured":"Al-Bayyari N, Al-Domi H, Zayed F, Hailat R, Eaton A. Androgens and hirsutism score of overweight women with polycystic ovary syndrome improved after vitamin D treatment: A randomized placebo controlled clinical trial. Clin Nutr. 2021;40(3):870\u20138.","journal-title":"Clin Nutr"},{"issue":"4","key":"1409_CR43","first-page":"222","volume":"126","author":"G Mirmasoumi","year":"2018","unstructured":"Mirmasoumi G, Fazilati M, Foroozanfard F, Vahedpoor Z, Mahmoodi S, Taghizadeh M, et al. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind. Placebo-Controlled Trial Exp Clin Endocrinol Diabetes. 2018;126(4):222\u20138.","journal-title":"Placebo-Controlled Trial Exp Clin Endocrinol Diabetes"},{"key":"1409_CR44","doi-asserted-by":"publisher","first-page":"64","DOI":"10.4103\/jrms.JRMS_644_16","volume":"22","author":"B Khani","year":"2017","unstructured":"Khani B, Mardanian F, Fesharaki SJ. Omega-3 supplementation effects on polycystic ovary syndrome symptoms and metabolic syndrome. J Res Med Sci. 2017;22:64.","journal-title":"J Res Med Sci"},{"issue":"4","key":"1409_CR45","first-page":"212","volume":"16","author":"A Nadjarzadeh","year":"2015","unstructured":"Nadjarzadeh A, Dehghani-Firouzabadi R, Daneshbodi H, Lotfi MH, Vaziri N, Mozaffari-Khosravi H. Effect of Omega-3 Supplementation on Visfatin, Adiponectin, and Anthropometric Indices in Women with Polycystic Ovarian Syndrome. J Reprod Infertil. 2015;16(4):212\u201320.","journal-title":"J Reprod Infertil"},{"issue":"6","key":"1409_CR46","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/cen.12699","volume":"82","author":"M Jamilian","year":"2015","unstructured":"Jamilian M, Razavi M, Fakhrie Kashan Z, Ghandi Y, Bagherian T, Asemi Z. Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clin Endocrinol (Oxf). 2015;82(6):885\u201391.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"1409_CR47","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1055\/s-0035-1559604","volume":"48","author":"M Razavi","year":"2016","unstructured":"Razavi M, Jamilian M, Kashan ZF, Heidar Z, Mohseni M, Ghandi Y, et al. Selenium Supplementation and the Effects on Reproductive Outcomes, Biomarkers of Inflammation, and Oxidative Stress in Women with Polycystic Ovary Syndrome. Horm Metab Res. 2016;48(3):185\u201390.","journal-title":"Horm Metab Res"},{"key":"1409_CR48","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jtemb.2016.01.002","volume":"34","author":"F Mohammad Hosseinzadeh","year":"2016","unstructured":"Mohammad Hosseinzadeh F, Hosseinzadeh-Attar MJ, Yekaninejad MS, Rashidi B. Effects of selenium supplementation on glucose homeostasis and free androgen index in women with polycystic ovary syndrome: A randomized, double blinded, placebo controlled clinical trial. J Trace Elem Med Biol. 2016;34:56\u201361.","journal-title":"J Trace Elem Med Biol"},{"key":"1409_CR49","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.clnesp.2022.07.017","volume":"51","author":"S Zadeh Modarres","year":"2022","unstructured":"Zadeh Modarres S, Asemi Z, Heidar Z. The effects of selenium supplementation on glycemic control, serum lipoproteins and biomarkers of oxidative stress in infertile women diagnosed with polycystic ovary syndrome undergoing in vitro fertilization: A randomized, double-blind, placebo-controlled trial. Clin Nutr ESPEN. 2022;51:92\u20136.","journal-title":"Clin Nutr ESPEN"},{"issue":"2","key":"1409_CR50","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s12011-019-01954-6","volume":"196","author":"BH Rashidi","year":"2020","unstructured":"Rashidi BH, Mohammad Hosseinzadeh F, Alipoor E, Asghari S, Yekaninejad MS, Hosseinzadeh-Attar MJ. Effects of Selenium Supplementation on Asymmetric Dimethylarginine and Cardiometabolic Risk Factors in Patients with Polycystic Ovary Syndrome. Biol Trace Elem Res. 2020;196(2):430\u20137.","journal-title":"Biol Trace Elem Res"},{"key":"1409_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153395","volume":"80","author":"J Heshmati","year":"2021","unstructured":"Heshmati J, Moini A, Sepidarkish M, Morvaridzadeh M, Salehi M, Palmowski A, et al. Effects of curcumin supplementation on blood glucose, insulin resistance and androgens in patients with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial. Phytomedicine. 2021;80: 153395.","journal-title":"Phytomedicine"},{"key":"1409_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2019.102201","volume":"47","author":"S Sohaei","year":"2019","unstructured":"Sohaei S, Amani R, Tarrahi MJ, Ghasemi-Tehrani H. The effects of curcumin supplementation on glycemic status, lipid profile and hs-CRP levels in overweight\/obese women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled clinical trial. Complement Ther Med. 2019;47: 102201.","journal-title":"Complement Ther Med"},{"key":"1409_CR53","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/978-3-030-64872-5_9","volume":"1308","author":"SM Sohrevardi","year":"2021","unstructured":"Sohrevardi SM, Heydari B, Azarpazhooh MR, Teymourzadeh M, Simental-Mend\u00eda LE, Atkin SL, et al. Therapeutic Effect of Curcumin in Women with Polycystic Ovary Syndrome Receiving Metformin: A Randomized Controlled Trial. Adv Exp Med Biol. 2021;1308:109\u201317.","journal-title":"Adv Exp Med Biol"},{"key":"1409_CR54","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.clnesp.2020.01.005","volume":"36","author":"M Jamilian","year":"2020","unstructured":"Jamilian M, Foroozanfard F, Kavossian E, Aghadavod E, Shafabakhsh R, Hoseini A, et al. Effects of curcumin on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. Clin Nutr ESPEN. 2020;36:128\u201333.","journal-title":"Clin Nutr ESPEN"},{"issue":"6","key":"1409_CR55","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/cen.13003","volume":"84","author":"M Samimi","year":"2016","unstructured":"Samimi M, Jamilian M, Ebrahimi FA, Rahimi M, Tajbakhsh B, Asemi Z. Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clin Endocrinol (Oxf). 2016;84(6):851\u20137.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1409_CR56","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4103\/ijpvm.IJPVM_2_18","volume":"10","author":"HR Talari","year":"2019","unstructured":"Talari HR, Azad ZJ, Hamidian Y, Samimi M, Gilasi HR, Ebrahimi Afshar F, Ostadmohammadi V, Asemi Z. Effects of Carnitine Administration on Carotid Intima-media Thickness and Inflammatory Factors in Patients with Polycystic Ovary Syndrome: A Randomized, Double-blind. Placebo-controlled Trial Int J Prev Med. 2019;10:89.","journal-title":"Placebo-controlled Trial Int J Prev Med"},{"issue":"3","key":"1409_CR57","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s00394-021-02659-0","volume":"61","author":"AA Sangouni","year":"2022","unstructured":"Sangouni AA, Pakravanfar F, Ghadiri-Anari A, Nadjarzadeh A, Fallahzadeh H, Hosseinzadeh M. The effect of L-carnitine supplementation on insulin resistance, sex hormone-binding globulin and lipid profile in overweight\/obese women with polycystic ovary syndrome: a randomized clinical trial. Eur J Nutr. 2022;61(3):1199\u2013207.","journal-title":"Eur J Nutr"},{"issue":"1","key":"1409_CR58","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12902-018-0248-0","volume":"18","author":"K Nasri","year":"2018","unstructured":"Nasri K, Jamilian M, Rahmani E, Bahmani F, Tajabadi-Ebrahimi M, Asemi Z. The effects of synbiotic supplementation on hormonal status, biomarkers of inflammation and oxidative stress in subjects with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. BMC Endocr Disord. 2018;18(1):21.","journal-title":"BMC Endocr Disord"},{"issue":"4","key":"1409_CR59","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1017\/S0007114517003920","volume":"119","author":"E Karimi","year":"2018","unstructured":"Karimi E, Moini A, Yaseri M, Shirzad N, Sepidarkish M, Hossein-Boroujerdi M, et al. Effects of synbiotic supplementation on metabolic parameters and apelin in women with polycystic ovary syndrome: a randomised double-blind placebo-controlled trial. Br J Nutr. 2018;119(4):398\u2013406.","journal-title":"Br J Nutr"},{"issue":"1","key":"1409_CR60","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12944-020-01244-4","volume":"19","author":"E Karimi","year":"2020","unstructured":"Karimi E, Heshmati J, Shirzad N, Vesali S, Hosseinzadeh-Attar MJ, Moini A, et al. The effect of synbiotics supplementation on anthropometric indicators and lipid profiles in women with polycystic ovary syndrome: a randomized controlled trial. Lipids Health Dis. 2020;19(1):60.","journal-title":"Lipids Health Dis"},{"issue":"9","key":"1409_CR61","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1210\/clinem\/dgab369","volume":"106","author":"I Chudzicka-Struga\u0142a","year":"2021","unstructured":"Chudzicka-Struga\u0142a I, Kubiak A, Banaszewska B, Zwozdziak B, Siakowska M, Pawelczyk L, et al. Effects of Synbiotic Supplementation and Lifestyle Modifications on Women with Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2021;106(9):2566\u201373.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1409_CR62","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s12602-018-9405-z","volume":"11","author":"M Samimi","year":"2019","unstructured":"Samimi M, Dadkhah A, Haddad Kashani H, Tajabadi-Ebrahimi M, Seyed Hosseini E, Asemi Z. The Effects of Synbiotic Supplementation on Metabolic Status in Women with Polycystic Ovary Syndrome: a Randomized Double-Blind Clinical Trial. Probiotics Antimicrob Proteins. 2019;11(4):1355\u201361.","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"1","key":"1409_CR63","first-page":"51","volume":"15","author":"S Darvishi","year":"2021","unstructured":"Darvishi S, Rafraf M, Asghari-Jafarabadi M, Farzadi L. Synbiotic Supplementation Improves Metabolic Factors and Obesity Values in Women with Polycystic Ovary Syndrome Independent of Affecting Apelin Levels: A Randomized Double-Blind Placebo - Controlled Clinical Trial. Int J Fertil Steril. 2021;15(1):51\u20139.","journal-title":"Int J Fertil Steril"},{"issue":"3","key":"1409_CR64","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/jog.12907","volume":"42","author":"S Ashoush","year":"2016","unstructured":"Ashoush S, Abou-Gamrah A, Bayoumy H, Othman N. Chromium picolinate reduces insulin resistance in polycystic ovary syndrome: Randomized controlled trial. J Obstet Gynaecol Res. 2016;42(3):279\u201385.","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"1409_CR65","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12011-015-0570-6","volume":"172","author":"M Jamilian","year":"2016","unstructured":"Jamilian M, Bahmani F, Siavashani MA, Mazloomi M, Asemi Z, Esmaillzadeh A. The Effects of Chromium Supplementation on Endocrine Profiles, Biomarkers of Inflammation, and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind. Placebo-Controlled Trial Biol Trace Elem Res. 2016;172(1):72\u20138.","journal-title":"Placebo-Controlled Trial Biol Trace Elem Res"},{"issue":"1","key":"1409_CR66","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000438465","volume":"67","author":"M Jamilian","year":"2015","unstructured":"Jamilian M, Asemi Z. Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind. Placebo-Controlled Trial Ann Nutr Metab. 2015;67(1):42\u20138.","journal-title":"Placebo-Controlled Trial Ann Nutr Metab"},{"issue":"1","key":"1409_CR67","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s12011-017-1236-3","volume":"185","author":"M Jamilian","year":"2018","unstructured":"Jamilian M, Zadeh Modarres S, Amiri Siavashani M, Karimi M, Mafi A, Ostadmohammadi V, et al. The Influences of Chromium Supplementation on Glycemic Control, Markers of Cardio-Metabolic Risk, and Oxidative Stress in Infertile Polycystic ovary Syndrome Women Candidate for In vitro Fertilization: a Randomized, Double-Blind. Placebo-Controlled Trial Biol Trace Elem Res. 2018;185(1):48\u201355.","journal-title":"Placebo-Controlled Trial Biol Trace Elem Res"},{"key":"1409_CR68","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3389\/fendo.2018.00726","volume":"9","author":"M Amiri Siavashani","year":"2018","unstructured":"Amiri Siavashani M, Zadeh Modarres S, Mirhosseini N, Aghadavod E, Salehpour S, Asemi Z. The Effects of Chromium Supplementation on Gene Expression of Insulin, Lipid, and Inflammatory Markers in Infertile Women with Polycystic Ovary Syndrome Candidate for in vitro Fertilization: A Randomized, Double-Blinded, Placebo-Controlled Trial. Front Endocrinol (Lausanne). 2018;9:726.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"1409_CR69","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1007\/s12011-021-02725-y","volume":"200","author":"R Mousavi","year":"2022","unstructured":"Mousavi R, Alizadeh M, Asghari Jafarabadi M, Heidari L, Nikbakht R, Babaahmadi Rezaei H, et al. Effects of Melatonin and\/or Magnesium Supplementation on Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind. Placebo-Controlled Trial Biol Trace Elem Res. 2022;200(3):1010\u20139.","journal-title":"Placebo-Controlled Trial Biol Trace Elem Res"},{"issue":"3","key":"1409_CR70","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s12011-023-03744-7","volume":"202","author":"S Shahmoradi","year":"2024","unstructured":"Shahmoradi S, Chiti H, Tavakolizadeh M, Hatami R, Motamed N, Ghaemi M. The Effect of Magnesium Supplementation on Insulin Resistance and Metabolic Profiles in Women with Polycystic Ovary Syndrome: a Randomized Clinical Trial. Biol Trace Elem Res. 2024;202(3):941\u20136.","journal-title":"Biol Trace Elem Res"},{"issue":"1","key":"1409_CR71","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12986-021-00586-9","volume":"18","author":"M Alizadeh","year":"2021","unstructured":"Alizadeh M, Karandish M, Asghari Jafarabadi M, Heidari L, Nikbakht R, Babaahmadi Rezaei H, et al. Metabolic and hormonal effects of melatonin and\/or magnesium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Nutr Metab (Lond). 2021;18(1):57.","journal-title":"Nutr Metab (Lond)"},{"key":"1409_CR72","doi-asserted-by":"crossref","unstructured":", holizadeh-Moghaddam M, Ghasemi-Tehrani H, Askari G, Jaripur M, Clark CCT, Rouhani MH. Effect of magnesium supplementation in improving hyperandrogenism, hirsutism, and sleep quality in women with polycystic ovary syndrome: A randomized, placebo-controlled clinical trial. Health Sci Rep. 2022;6(1): e1013.","DOI":"10.1002\/hsr2.1013"},{"issue":"2","key":"1409_CR73","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s12011-015-0480-7","volume":"170","author":"M Jamilian","year":"2016","unstructured":"Jamilian M, Foroozanfard F, Bahmani F, Talaee R, Monavari M, Asemi Z. Effects of Zinc Supplementation on Endocrine Outcomes in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind. Placebo-Controlled Trial Biol Trace Elem Res. 2016;170(2):271\u20138.","journal-title":"Placebo-Controlled Trial Biol Trace Elem Res"},{"issue":"4","key":"1409_CR74","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1055\/s-0035-1548790","volume":"123","author":"F Foroozanfard","year":"2015","unstructured":"Foroozanfard F, Jamilian M, Jafari Z, Khassaf A, Hosseini A, Khorammian H, et al. Effects of zinc supplementation on markers of insulin resistance and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Exp Clin Endocrinol Diabetes. 2015;123(4):215\u201320.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"2","key":"1409_CR75","first-page":"319","volume":"104","author":"A Izadi","year":"2019","unstructured":"Izadi A, Ebrahimi S, Shirazi S, Taghizadeh S, Parizad M, Farzadi L, Gargari BP. Hormonal and Metabolic Effects of Coenzyme Q10 and\/or Vitamin E in Patients with Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2019;104(2):319\u201327.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1409_CR76","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/cen.13288","volume":"86","author":"M Samimi","year":"2017","unstructured":"Samimi M, Zarezade Mehrizi M, Foroozanfard F, Akbari H, Jamilian M, Ahmadi S, et al. The effects of coenzyme Q10 supplementation on glucose metabolism and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clin Endocrinol (Oxf). 2017;86(4):560\u20136.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"1409_CR77","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/09513590.2021.1991910","volume":"38","author":"M Karamali","year":"2022","unstructured":"Karamali M, Gholizadeh M. The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome. Gynecol Endocrinol. 2022;38(1):45\u20139.","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"1409_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arcmed.2019.04.004","volume":"50","author":"A Izadi","year":"2019","unstructured":"Izadi A, Shirazi S, Taghizadeh S, Gargari BP. Independent and Additive Effects of Coenzyme Q10 and Vitamin E on Cardiometabolic Outcomes and Visceral Adiposity in Women with Polycystic Ovary Syndrome. Arch Med Res. 2019;50(2):1\u201310.","journal-title":"Arch Med Res"},{"issue":"1","key":"1409_CR79","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/09513590.2020.1779689","volume":"37","author":"S Taghizadeh","year":"2021","unstructured":"Taghizadeh S, Izadi A, Shirazi S, Parizad M, Pourghassem GB. The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight\/obese polycystic ovary syndrome patients. Gynecol Endocrinol. 2021;37(1):26\u201330.","journal-title":"Gynecol Endocrinol"},{"key":"1409_CR80","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jad.2019.02.066","volume":"250","author":"A Shabani","year":"2019","unstructured":"Shabani A, Foroozanfard F, Kavossian E, Aghadavod E, Ostadmohammadi V, Reiter RJ, et al. Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. J Affect Disord. 2019;250:51\u20136.","journal-title":"J Affect Disord"},{"key":"1409_CR81","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fendo.2019.00273","volume":"10","author":"M Jamilian","year":"2019","unstructured":"Jamilian M, Foroozanfard F, Mirhosseini N, Kavossian E, Aghadavod E, Bahmani F, Ostadmohammadi V, et al. Effects of Melatonin Supplementation on Hormonal, Inflammatory, Genetic, and Oxidative Stress Parameters in Women with Polycystic Ovary Syndrome. Front Endocrinol (Lausanne). 2019;10:273.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"1409_CR82","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1210\/jc.2016-1762","volume":"101","author":"M Jamilian","year":"2016","unstructured":"Jamilian M, Asemi Z. The Effects of Soy Isoflavones on Metabolic Status of Patients with Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2016;101(9):3386\u201394.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1409_CR83","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/jhn.12545","volume":"31","author":"M Karamali","year":"2018","unstructured":"Karamali M, Kashanian M, Alaeinasab S, Asemi Z. The effect of dietary soy intake on weight loss, glycaemic control, lipid profiles and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome: a randomised clinical trial. J Hum Nutr Diet. 2018;31(4):533\u201343.","journal-title":"J Hum Nutr Diet"},{"issue":"2","key":"1409_CR84","first-page":"102","volume":"16","author":"S Janati","year":"2022","unstructured":"Janati S, Behmanesh MA, Najafzadehvarzi H, Kassani A, Athari N, Poormoosavi SM. Changes of Serum Level of Homocysteine and Oxidative Stress Markers by Metformin and Inositol in Infertile Women with Polycystic Ovary Syndrome: A Double Blind Randomized Clinical Trial Study. Int J Fertil Steril. 2022;16(2):102\u20137.","journal-title":"Int J Fertil Steril"},{"issue":"2","key":"1409_CR85","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/cen.13366","volume":"87","author":"M Jamilian","year":"2017","unstructured":"Jamilian M, Farhat P, Foroozanfard F, Afshar Ebrahimi F, Aghadavod E, Bahmani F, et al. Comparison of myo-inositol and metformin on clinical, metabolic and genetic parameters in polycystic ovary syndrome: A randomized controlled clinical trial. Clin Endocrinol (Oxf). 2017;87(2):194\u2013200.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"1409_CR86","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1080\/09513590.2018.1540570","volume":"35","author":"M Shokrpour","year":"2019","unstructured":"Shokrpour M, Foroozanfard F, Afshar Ebrahimi F, Vahedpoor Z, Aghadavod E, Ghaderi A, et al. Comparison of myo-inositol and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with polycystic ovary syndrome: a randomized controlled clinical trial. Gynecol Endocrinol. 2019;35(5):406\u201311.","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"1409_CR87","first-page":"105","volume":"13","author":"D Costantino","year":"2009","unstructured":"Costantino D, Minozzi G, Minozzi E, Guaraldi C. Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial. Eur Rev Med Pharmacol Sci. 2009;13(2):105\u201310.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"1409_CR88","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3109\/09513590.2012.743020","volume":"29","author":"PG Artini","year":"2013","unstructured":"Artini PG, Di Berardino OM, Papini F, Genazzani AD, Simi G, Ruggiero M, et al. Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study Gynecol Endocrinol. 2013;29(4):375\u20139.","journal-title":"A randomized study Gynecol Endocrinol"},{"key":"1409_CR89","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1007\/s00394-022-02959-z","volume":"61","author":"I Kaur","year":"2022","unstructured":"Kaur I, Suri V, Sachdeva N, et al. Efficacy of multi-strain probiotic along with dietary and lifestyle modifications on polycystic ovary syndrome: a randomised, double-blind placebo-controlled study. Eur J Nutr. 2022;61:4145\u201354.","journal-title":"Eur J Nutr"},{"issue":"1","key":"1409_CR90","first-page":"1","volume":"21","author":"M Karamali","year":"2018","unstructured":"Karamali M, Eghbalpour S, Rajabi S, Jamilian M, Bahmani F, Tajabadi-Ebrahimi M, et al. Effects of Probiotic Supplementation on Hormonal Profiles, Biomarkers of Inflammation and Oxidative Stress in Women With Polycystic Ovary Syndrome: A Randomized, Double-Blind. Placebo-Controlled Trial Arch Iran Med. 2018;21(1):1\u20137.","journal-title":"Placebo-Controlled Trial Arch Iran Med"},{"key":"1409_CR91","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/2008-7802.153866","volume":"6","author":"T Shoaei","year":"2015","unstructured":"Shoaei T, Heidari-Beni M, Tehrani HG, Feizi A, Esmaillzadeh A, Askari G. Effects of Probiotic Supplementation on Pancreatic \u03b2-cell Function and C-reactive Protein in Women with Polycystic Ovary Syndrome: A Randomized Double-blind Placebo-controlled Clinical Trial. Int J Prev Med. 2015;6:27.","journal-title":"Int J Prev Med"},{"key":"1409_CR92","doi-asserted-by":"crossref","unstructured":"Nila Ghanei, Nima Rezaei, Ghorban Ali Amiri, Farid Zayeri, Golbou Makki, Esmat Nasseri. The probiotic supplementation reduced inflammation in polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial, Journal of Functional. 2018, 06\u2013311.","DOI":"10.1016\/j.jff.2017.12.047"},{"issue":"4","key":"1409_CR93","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/cen.12451","volume":"81","author":"F Bahmani","year":"2014","unstructured":"Bahmani F, Karamali M, Shakeri H, Asemi Z. The effects of folate supplementation on inflammatory factors and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial. Clin Endocrinol (Oxf). 2014;81(4):582\u20137.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"1409_CR94","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/mnfr.201400033","volume":"58","author":"Z Asemi","year":"2014","unstructured":"Asemi Z, Karamali M, Esmaillzadeh A. Metabolic response to folate supplementation in overweight women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. Mol Nutr Food Res. 2014;58(7):1465\u201373.","journal-title":"Mol Nutr Food Res"},{"key":"1409_CR95","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jad.2018.05.027","volume":"238","author":"M Jamilian","year":"2018","unstructured":"Jamilian M, Samimi M, Mirhosseini N, Afshar Ebrahimi F, Aghadavod E, Talaee R, et al. The influences of vitamin D and omega-3 co-supplementation on clinical, metabolic and genetic parameters in women with polycystic ovary syndrome. J Affect Disord. 2018;238:32\u20138.","journal-title":"J Affect Disord"},{"issue":"1","key":"1409_CR96","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13048-019-0480-x","volume":"12","author":"V Ostadmohammadi","year":"2019","unstructured":"Ostadmohammadi V, Jamilian M, Bahmani F, Asemi Z. Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome. J Ovarian Res. 2019;12(1):5.","journal-title":"J Ovarian Res"},{"issue":"5\u20136","key":"1409_CR97","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1024\/0300-9831\/a000588","volume":"90","author":"F Sadeghi","year":"2020","unstructured":"Sadeghi F, Alavi-Naeini A, Mardanian F, Ghazvini MR, Mahaki B. Omega-3 and vitamin E co-supplementation can improve antioxidant markers in obese\/overweight women with polycystic ovary syndrome. Int J Vitam Nutr Res. 2020;90(5\u20136):477\u201383.","journal-title":"Int J Vitam Nutr Res"},{"issue":"6","key":"1409_CR98","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1055\/s-0042-117773","volume":"125","author":"FA Ebrahimi","year":"2017","unstructured":"Ebrahimi FA, Samimi M, Foroozanfard F, Jamilian M, Akbari H, Rahmani E, et al. The Effects of Omega-3 Fatty Acids and Vitamin E Co-Supplementation on Indices of Insulin Resistance and Hormonal Parameters in Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind. Placebo-Controlled Trial Exp Clin Endocrinol Diabetes. 2017;125(6):353\u20139.","journal-title":"Placebo-Controlled Trial Exp Clin Endocrinol Diabetes"},{"key":"1409_CR99","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.mce.2016.09.008","volume":"5439","author":"E Rahmani","year":"2017","unstructured":"Rahmani E, Samimi M, Ebrahimi FA, Foroozanfard F, Ahmadi S, Rahimi M, et al. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome. Mol Cell Endocrinol. 2017;5439:247\u201355.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"1409_CR100","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s12011-018-1602-9","volume":"191","author":"M Shokrpour","year":"2019","unstructured":"Shokrpour M, Asemi Z. The Effects of Magnesium and Vitamin E Co-Supplementation on Hormonal Status and Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome. Biol Trace Elem Res. 2019;191(1):54\u201360.","journal-title":"Biol Trace Elem Res"},{"issue":"2","key":"1409_CR101","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1055\/a-0749-6431","volume":"51","author":"M Jamilian","year":"2019","unstructured":"Jamilian M, Sabzevar NK, Asemi Z. The Effect of Magnesium and Vitamin E Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind. Placebo-Controlled Trial Horm Metab Res. 2019;51(2):100\u20135.","journal-title":"Placebo-Controlled Trial Horm Metab Res"},{"issue":"2","key":"1409_CR102","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s12011-017-1198-5","volume":"184","author":"F Afshar Ebrahimi","year":"2018","unstructured":"Afshar Ebrahimi F, Foroozanfard F, Aghadavod E, Bahmani F, Asemi Z. The Effects of Magnesium and Zinc Co-Supplementation on Biomarkers of Inflammation and Oxidative Stress, and Gene Expression Related to Inflammation in Polycystic Ovary Syndrome: a Randomized Controlled Clinical Trial. Biol Trace Elem Res. 2018;184(2):300\u20137.","journal-title":"Biol Trace Elem Res"},{"issue":"2","key":"1409_CR103","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s12011-019-01720-8","volume":"193","author":"M Jamilian","year":"2020","unstructured":"Jamilian M, Foroozanfard F, Kavossian E, Kia M, Aghadavod E, Amirani E, et al. Effects of Chromium and Carnitine Co-supplementation on Body Weight and Metabolic Profiles in Overweight and Obese Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind. Placebo-Controlled Trial Biol Trace Elem Res. 2020;193(2):334\u201341.","journal-title":"Placebo-Controlled Trial Biol Trace Elem Res"},{"key":"1409_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/0167482X.2018.1557144","volume":"5","author":"M Jamilian","year":"2019","unstructured":"Jamilian M, Foroozanfard F, Kavossian E, Aghadavod E, Amirani E, Mahdavinia M, et al. Carnitine and chromium co-supplementation affects mental health, hormonal, inflammatory, genetic, and oxidative stress parameters in women with polycystic ovary syndrome. J Psychosom Obstet Gynaecol. 2019;5:1\u20139.","journal-title":"J Psychosom Obstet Gynaecol"},{"issue":"1","key":"1409_CR105","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13048-018-0457-1","volume":"11","author":"M Jamilian","year":"2018","unstructured":"Jamilian M, Mansury S, Bahmani F, Heidar Z, Amirani E, Asemi Z. The effects of probiotic and selenium co-supplementation on parameters of mental health, hormonal profiles, and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome. J Ovarian Res. 2018;11(1):80.","journal-title":"J Ovarian Res"},{"issue":"7","key":"1409_CR106","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1055\/s-0042-104060","volume":"48","author":"M Razavi","year":"2016","unstructured":"Razavi M, Jamilian M, Karamali M, Bahmani F, Aghadavod E, Asemi Z. The Effects of Vitamin D-K-Calcium Co-Supplementation on Endocrine, Inflammation, and Oxidative Stress Biomarkers in Vitamin D-Deficient Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind. Placebo-Controlled Trial Horm Metab Res. 2016;48(7):446\u201351.","journal-title":"Placebo-Controlled Trial Horm Metab Res"},{"issue":"5","key":"1409_CR107","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1055\/s-0043-104530","volume":"125","author":"M Karamali","year":"2017","unstructured":"Karamali M, Ashrafi M, Razavi M, Jamilian M, Akbari M, Asemi Z. The Effects of Calcium, Vitamins D and K co-Supplementation on Markers of Insulin Metabolism and Lipid Profiles in Vitamin D-Deficient Women with Polycystic Ovary Syndrome. Exp Clin Endocrinol Diabetes. 2017;125(5):316\u201321.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"10","key":"1409_CR108","first-page":"640","volume":"20","author":"M Jamilian","year":"2017","unstructured":"Jamilian M, Maktabi M, Asemi Z. A Trial on The Effects of Magnesium-Zinc-Calcium-Vitamin D Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome. Arch Iran Med. 2017;20(10):640\u20135.","journal-title":"Arch Iran Med"},{"issue":"2","key":"1409_CR109","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00394-018-1648-7","volume":"58","author":"S Gholizadeh Shamasbi","year":"2019","unstructured":"Gholizadeh Shamasbi S, Dehgan P, Mohammad-Alizadeh Charandabi S, Aliasgarzadeh A, Mirghafourvand M. The effect of resistant dextrin as a prebiotic on metabolic parameters and androgen level in women with polycystic ovarian syndrome: a randomized, triple-blind, controlled, clinical trial. Eur J Nutr. 2019;58(2):629\u201340.","journal-title":"Eur J Nutr"},{"issue":"9","key":"1409_CR110","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602\u201318.","journal-title":"Hum Reprod"},{"issue":"11","key":"1409_CR111","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.4158\/EP15748.DSC","volume":"21","author":"NF Goodman","year":"2015","unstructured":"Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and Pcos Society Disease State clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome-part 1. Endocr Pract. 2015;21(11):1291\u2013300.","journal-title":"Endocr Pract"},{"issue":"8","key":"1409_CR112","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1007\/s43032-022-00933-y","volume":"29","author":"H Jethaliya","year":"2022","unstructured":"Jethaliya H, Gajjar N, Patel V, Deshpande S, Patel R. Efficacy of Myo-inositol on Anthropometric, Metabolic, and Endocrine Outcomes in PCOS Patients: a Meta-analysis of Randomized Controlled Trial. Reprod Sci. 2022;29(8):2282\u201398.","journal-title":"Reprod Sci"},{"key":"1409_CR113","doi-asserted-by":"publisher","first-page":"1141355","DOI":"10.3389\/fmed.2023.1141355","volume":"10","author":"P Angoorani","year":"2023","unstructured":"Angoorani P, Ejtahed HS, Ettehad Marvasti F, Taghavi M, Mohammadpour Ahranjani B, Hasani-Ranjbar S, et al. The effects of probiotics, prebiotics, and synbiotics on polycystic ovarian syndrome: an overview of systematic reviews. Front Med (Lausanne). 2023;10:1141355.","journal-title":"Front Med (Lausanne)"},{"key":"1409_CR114","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.16410","volume":"11","author":"X Hu","year":"2023","unstructured":"Hu X, Wang W, Su X, Peng H, Tan Z, Li Y, Hu X, Wang W, Su X, Peng H, Tan Z, Li Y, Huang Y. Comparison of nutritional supplements in improving glycolipid metabolism and endocrine function in polycystic ovary syndrome: a systematic review and network meta-analysis. Peer J. 2023;11: e16410.","journal-title":"Peer J"},{"key":"1409_CR115","doi-asserted-by":"crossref","unstructured":"Rudnicka E, Duszewska AM, Kucharski M, Tyczy\u0144ski P, Smolarczyk R. oxidative stress and reproductive function: Oxidative stress in polycystic ovary syndrome. Reproduction. 2022 2;164(6): F145-F154.","DOI":"10.1530\/REP-22-0152"},{"issue":"3","key":"1409_CR116","doi-asserted-by":"publisher","first-page":"R11","DOI":"10.1530\/JME-21-0177","volume":"68","author":"M Malamouli","year":"2022","unstructured":"Malamouli M, Levinger I, McAinch AJ, Trewin AJ, Rodgers RJ, Moreno-Asso A. The mitochondrial profile in women with polycystic ovary syndrome: impact of exercise. J Mol Endocrinol. 2022;68(3):R11\u201323.","journal-title":"J Mol Endocrinol"},{"key":"1409_CR117","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.mito.2020.02.006","volume":"52","author":"P Shukla","year":"2020","unstructured":"Shukla P, Mukherjee S. Mitochondrial dysfunction: An emerging link in the pathophysiology of polycystic ovary syndrome. Mitochondrion. 2020;52:24\u201339.","journal-title":"Mitochondrion"},{"issue":"10","key":"1409_CR118","doi-asserted-by":"publisher","first-page":"5352","DOI":"10.1002\/ptr.7144","volume":"35","author":"A Hosseini","year":"2021","unstructured":"Hosseini A, Razavi BM, Banach M, Hosseinzadeh H. Quercetin and metabolic syndrome: a review. Phytother Res. 2021;35(10):5352\u201364.","journal-title":"Phytother Res"},{"issue":"6","key":"1409_CR119","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1017\/S0007114520003207","volume":"125","author":"JAG Tosatti","year":"2021","unstructured":"Tosatti JAG, Alves MT, C\u00e2ndido AL, Reis FM, Ara\u00fajo VE, Gomes KB. Influence of n-3 fatty acid supplementation on inflammatory and oxidative stress markers in patients with polycystic ovary syndrome: a systematic review and meta-analysis. Br J Nutr. 2021;125(6):657\u201368.","journal-title":"Br J Nutr"},{"issue":"7","key":"1409_CR120","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.3390\/antiox12071398","volume":"12","author":"T Srnovr\u0161nik","year":"2023","unstructured":"Srnovr\u0161nik T, Virant-Klun I, Pinter B. Heavy Metals and Essential Elements in Association with Oxidative Stress in Women with Polycystic Ovary Syndrome-A Systematic Review. Antioxidants (Basel). 2023;12(7):1398.","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"1409_CR121","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12958-023-01055-z","volume":"21","author":"D Greff","year":"2023","unstructured":"Greff D, Juh\u00e1sz AE, V\u00e1ncsa S, V\u00e1radi A, Sipos Z, Szinte J, et al. Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Reprod Biol Endocrinol. 2023;21(1):10.","journal-title":"Reprod Biol Endocrinol"},{"issue":"2","key":"1409_CR122","first-page":"144","volume":"34","author":"LL Wang","year":"2014","unstructured":"Wang LL, Li C, Meng JP, Yang X. Effect of curcumin on expression of VEGF in polycystic ovary syndrome rat models. J Shanghai Jiaotong University (Medical Science). 2014;34(2):144\u20138.","journal-title":"J Shanghai Jiaotong University (Medical Science)"},{"key":"1409_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118003","volume":"256","author":"NZ Abuelezz","year":"2020","unstructured":"Abuelezz NZ, Shabana ME, Abdel-Mageed HM, Rashed L, Morcos GNB. Nanocurcumin alleviates insulin resistance and pancreatic deficits in polycystic ovary syndrome rats: Insights on PI3K\/AkT\/mTOR and TNF-a modulations. Life Sci. 2020;256: 118003.","journal-title":"Life Sci"},{"issue":"4","key":"1409_CR124","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3390\/metabo12040338","volume":"12","author":"T ElObeid","year":"2022","unstructured":"ElObeid T, Awad MO, Ganji V, Moawad J. The Impact of Mineral Supplementation on Polycystic Ovarian Syndrome. Metabolites. 2022;12(4):338.","journal-title":"Metabolites"},{"issue":"2","key":"1409_CR125","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1080\/09513590.2021.1988559","volume":"38","author":"D Liao","year":"2022","unstructured":"Liao D, Liu X, Yuan X, Feng P, Ouyang Z, Liu Y, et al. Clinical evidence of the effects of carnitine supplementation on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: a systematic review and meta-analysis. Gynecol Endocrinol. 2022;38(2):110\u20135.","journal-title":"Gynecol Endocrinol"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-025-01409-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-025-01409-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-025-01409-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T07:03:44Z","timestamp":1751526224000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-025-01409-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":125,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1409"],"URL":"https:\/\/doi.org\/10.1186\/s12958-025-01409-9","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"3 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All outcomes and analyses were based on previous ethically approved studies. Therefore, no further ethical approval and patient consent were required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}